Researchers report that testosterone replacement therapy (TRT) may be associated with cardiovascular rhythm problems, particularly atrial fibrillation, especially when hormone levels change sharply. The accounts describe that clinicians and researchers consider the potential mechanism to be linked to swings in testosterone that can occur during treatment.
The reporting frames the issue as a stroke-related warning because atrial fibrillation can increase the risk of stroke. The outlets stress that TRT is widely used by men who have low testosterone, and they characterize the concern as relevant to a large population. However, the coverage is focused on the potential risk rather than reporting new clinical outcomes for individual patients.
Across the sources provided, the main difference is emphasis: one highlights the broader “stroke warning,” while the underlying claim centers on atrial fibrillation as the proposed pathway. Both cite research rather than making a direct claim that TRT definitively causes strokes.
